Technical Analysis for ROSGQ - Rosetta Genomics Ltd

Grade Last Price % Change Price Change
grade F 0.0042 -6.67% -0.0003
ROSGQ closed down 6.67 percent on Tuesday, August 20, 2019, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ROSGQ trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -6.67%
Pocket Pivot Bullish Swing Setup -6.67%
Wide Bands Range Expansion -6.67%
Gapped Up Strength -6.67%
Oversold Stochastic Weakness -6.67%
Narrow Range Bar Range Contraction 5.00%

Older signals for ROSGQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.
RTT Branches Of Biology Cancer Oncology Prostate Cancer Tumor Diagnostic Tests Melanoma Bladder Cancer Non Small Cell Lung Cancer Genetics Infectious Causes Of Cancer Metastatic Cancer Hybridization Non Small Cell Lung Carcinoma Ros1
Is ROSGQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.063
52 Week Low 0.0001
Average Volume 36,088
200-Day Moving Average 0.0079
50-Day Moving Average 0.0069
20-Day Moving Average 0.0055
10-Day Moving Average 0.0049
Average True Range 0.0019
ADX 13.9
+DI 40.6593
-DI 24.5421
Chandelier Exit (Long, 3 ATRs ) 0.003899999999999999
Chandelier Exit (Short, 3 ATRs ) 0.0097
Upper Bollinger Band 0.0088
Lower Bollinger Band 0.0022
Percent B (%b) 0.3
BandWidth 120.0
MACD Line -0.0009
MACD Signal Line -0.0008
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0042
Resistance 3 (R3) 0.0042 0.0042 0.0042
Resistance 2 (R2) 0.0042 0.0042 0.0042 0.0042
Resistance 1 (R1) 0.0042 0.0042 0.0042 0.0042 0.0042
Pivot Point 0.0042 0.0042 0.0042 0.0042 0.0042
Support 1 (S1) 0.0042 0.0042 0.0042 0.0042 0.0042
Support 2 (S2) 0.0042 0.0042 0.0042 0.0042
Support 3 (S3) 0.0042 0.0042 0.0042
Support 4 (S4) 0.0042